AcelRx Pharmaceuticals Inc

ACRX 
(NASDAQ) 
 
$ 3.050
Updated 14/08/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 22,865
High $ 3.100
Low $ 3.000
Open $ 3.100
ISIN
Prev close $ 3.050
# of shares 60.60M
Market cap 184.83M USD
Intraday

Market closed
AcelRx Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  3.05 0.0% Stock price unchanged -4.7% Stock price decreasing 8.9% Stock price increasing 74.3% Stock price increasing 2.5% Stock price increasing
Powered by TradingView

News about AcelRx Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of the therapies for the treatment of moderate to severe acute pain. Its main product candidates include Dsuvia, Zalviso, and ARX-04. The company generates the revenue from collaboration agreements which includes license fees, cost reimbursement, development and manufacturing services, payments and royalties.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
15 August 2018 05:46:44
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180814.1 - EUROWEB7 - 2018-08-15 06:46:44 - 2018-08-15 05:46:44 - 1000 - Website: OKAY